ES2113338T3 - Clonado molecular y expresion de il-3 humano. - Google Patents

Clonado molecular y expresion de il-3 humano.

Info

Publication number
ES2113338T3
ES2113338T3 ES87202566T ES87202566T ES2113338T3 ES 2113338 T3 ES2113338 T3 ES 2113338T3 ES 87202566 T ES87202566 T ES 87202566T ES 87202566 T ES87202566 T ES 87202566T ES 2113338 T3 ES2113338 T3 ES 2113338T3
Authority
ES
Spain
Prior art keywords
produced
expression
human
molecular cloning
cadn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87202566T
Other languages
English (en)
Inventor
Lambertus Christiaan Dorssers
Gerard Dr Wagemaker
Yvonne Johanna Vos
Leen Robert Willem Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Application granted granted Critical
Publication of ES2113338T3 publication Critical patent/ES2113338T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE HA DISPUESTO EN SISTEMAS DE EXPRESION UN CADN QUE CODIFICA LA INTERLEUCINA-3 HUMANA, DESIGNADA AQUI COMO H IL-3 O H MULTI-CSF DANDO LUGAR A QUE SE PRODUZCA HIL-3 SUSTANCIALMENTE LIBRE DE LAS IMPUREZAS QUE ACOMPAÑAN NORMALMENTE A ESTA PROTEINA, POR EJEMPLO CUANDO ES PRODUCIDA ENTRE OTRAS POR LOS LINFOCITOS DE LA SANGRE PERIFERICA. LA H IL-3 RESULTANTE PUEDE SER PRODUCIDA EN CANTIDADES IMPORTANTES Y ES UTIL PARA UNA SERIE DE FINES TERAPEUTICOS Y DE DIAGNOSTICO.
ES87202566T 1986-12-16 1987-12-16 Clonado molecular y expresion de il-3 humano. Expired - Lifetime ES2113338T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP86202285 1986-12-16
EP87201322 1987-07-13

Publications (1)

Publication Number Publication Date
ES2113338T3 true ES2113338T3 (es) 1998-05-01

Family

ID=26103432

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87202566T Expired - Lifetime ES2113338T3 (es) 1986-12-16 1987-12-16 Clonado molecular y expresion de il-3 humano.

Country Status (14)

Country Link
JP (2) JPH01502157A (es)
AT (1) ATE161882T1 (es)
AU (1) AU617095B2 (es)
CA (1) CA1341503C (es)
DE (1) DE3752158T2 (es)
ES (1) ES2113338T3 (es)
FI (1) FI102293B (es)
GR (1) GR3025857T3 (es)
IE (1) IE81129B1 (es)
IL (1) IL84852A (es)
NO (1) NO180544C (es)
NZ (1) NZ222939A (es)
PT (1) PT86381B (es)
WO (1) WO1988004691A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
US6238889B1 (en) 1986-12-16 2001-05-29 Dsm N.V. Molecular cloning and expression of the Pro8 isoform of human IL-3
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
US5304637A (en) * 1987-07-13 1994-04-19 Gist-Brocades N.V. Expression and purification of human interleukin-3 and muteins thereof
GB2210883B (en) * 1987-10-08 1992-01-02 British Bio Technology Synthetic interleukin-3 gene
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
AU3864089A (en) * 1988-07-20 1990-02-19 Immunex Corporation Nonglycosylated human interleukin-3 compositions
NZ232913A (en) * 1989-03-15 1992-08-26 Gist Brocades Nv Il-3 produced recombinantly and purified to homogeneity; vectors and pharmaceutical preparations
US5128450A (en) * 1989-06-30 1992-07-07 Urdal David L Nonglycosylated human interleukin-3 analog proteins
DE69030937T2 (de) 1989-08-14 1997-10-09 Gist Brocades Nv Mutanten von Interleukin-3
US5516512A (en) 1989-08-14 1996-05-14 Gist-Brocades, N.V. N- and C-terminal truncation and deletion mutants of human interleukin-3
EP0596881B1 (fr) * 1991-08-01 1997-03-19 Fondation Nationale De Transfusion Sanguine Expression dans des lignees lymphoblastoides humaines non-tumorales avec un vecteur integratif
JPH08503706A (ja) * 1992-11-24 1996-04-23 ジー．ディー．サール アンド カンパニー インターロイキン−３（ｉｌ−３）多重変異ポリペプチド
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
WO1999041382A2 (en) * 1998-02-17 1999-08-19 Hyseq, Inc. A novel interleukin-3 and uses thereof
JP2008527981A (ja) * 2005-01-25 2008-07-31 アポロ ライフ サイエンシズ リミテッド 治療目的および診断目的のためにパラメーターにより選択されたｇｍ−ｃｓｆ、ｉｌ−３、ｉｌ−４、ｉｌ−５、ならびにそのキメラ
US8361750B2 (en) * 2006-04-03 2013-01-29 New England Biolabs, Inc. rBSA from K. lactis expression, secretion and purification of recombinant bovine serum albumin (rBSA) from K. lactis and uses thereof
WO2024033522A1 (en) 2022-08-11 2024-02-15 Universitätsklinikum Regensburg Antibodies targeting il3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695542A (en) * 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
AU570762B2 (en) * 1983-12-23 1988-03-24 Australian National University, The Cloning of cdna for il-3
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors

Also Published As

Publication number Publication date
NO883614L (no) 1988-08-12
IE81129B1 (en) 2000-03-22
IE873409L (en) 1988-06-12
FI883688L (fi) 1988-08-08
PT86381A (en) 1988-01-01
JPH1080286A (ja) 1998-03-31
AU1057788A (en) 1988-07-15
CA1341503C (en) 2006-04-04
PT86381B (pt) 1990-11-20
AU617095B2 (en) 1991-11-21
DE3752158T2 (de) 1998-05-20
JPH01502157A (ja) 1989-08-03
NO180544B (no) 1997-01-27
ATE161882T1 (de) 1998-01-15
NO180544C (no) 1997-05-07
FI102293B1 (fi) 1998-11-13
FI883688A0 (fi) 1988-08-08
FI102293B (fi) 1998-11-13
WO1988004691A1 (en) 1988-06-30
NZ222939A (en) 1991-03-26
GR3025857T3 (en) 1998-04-30
IL84852A (en) 1994-06-24
IL84852A0 (en) 1988-06-30
DE3752158D1 (de) 1998-02-12
NO883614D0 (no) 1988-08-12

Similar Documents

Publication Publication Date Title
Trinchieri et al. Response of resting human peripheral blood natural killer cells to interleukin 2.
ES2130120T3 (es) Procedimiento para la preparacion de la adnasa humana.
ES2153444T3 (es) Anticuerpos contra interleucina-4 mamifera, y peptidos utiles como antigenos en su produccion.
ES2068791T1 (es) Metodos y acido desoxirribonucleico para la preparacion de proteina de factor de tejido.
ES2145280T3 (es) Nuevas proteinas mutadas de hil-4 como antagonistas parciales de la interleuquina 4 humana.
ES2072323T3 (es) Compuestos de piperidina y su preparacion y empleo.
ES2007341A6 (es) Un procedimiento para producir m-csf
ES533054A0 (es) Un metodo para producir un gen que contiene una muteina sintetica de una proteina biologicamente activa
SE8501709D0 (sv) Improvements in or relating to intrleukin therapy
GR3002487T3 (en) Medicament with anti-tumoral action containing hexadecylphosphocholine
ATE44649T1 (de) Glykosylierte insulinabkoemmlinge.
IT8467445A1 (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea.
ATE161882T1 (de) Molekulare klonierung und expression von menschlichem il-3
ES2072251T3 (es) Composiciones y metodos para la sintesis y ensayo de enquefalinasa.
ES2092486T3 (es) Produccion y purificacion de interleucina-3 humana recombinante y muteinas de la misma.
FI885807L (fi) Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen
FR2598433B1 (fr) Procede de production d'interleukine-2 humaine, interleukine-2 ainsi obtenue, son utilisation a titre de medicament et composition pharmaceutique la contenant
BR8700576A (pt) Composicao,com hidrolise e cura,provendo um revestimento,membro revestido e refletor para aumentar a quantidade de luz util
ES2169080T3 (es) Inhibidor de la agregacion de plaquetas estimulada por colageno.
ES2119165T3 (es) Nueva actividad de cofactor anticoagulante.
ES2057004T3 (es) N-alcoxialquilamidas de hidroxiacidos y composiciones a base de las mismas para el tratamiento de la piel.
DE3586194D1 (de) Bioemulgatoren enthaltende kosmetische und pharmazeutische zusammensetzungen.
ES2037709T3 (es) Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas.
MX168061B (es) Hidrolizado de proteinas mejorado
ES2086409T3 (es) Imidazolinas sustituidas en posicion 2 y preparacion y uso de las mismas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 275598

Country of ref document: ES